Market intelligence for companies competing in the health plan market.
Live Last read · last published · next check
What the SNP composition rotation, the Star Ratings program breakdown, and the January 2027 supplemental benefit deadline change about how plans buy, vendors sell, and investors position for 2027.
Six of the largest publicly traded health plans raised guidance in Q2. The commitments they made underneath the raise are why vendor deals are stuck right now.
A new CMS demonstration is reshaping how your buyer thinks about 2027 coverage decisions, across every line of business.
One federal law, three markets absorbing it three different ways. What each is producing for members, providers, plans, and vendors.
A $2.5 billion sale collapsed on Mardi Gras night two years ago and ended a 28-year for-profit playbook. The nonprofit affiliation wave that replaced it is the story of Blues consolidation now.
Fourteen major health plans just signed a pledge to align by January 2028. Here's what changes about how health plans evaluate outcome-based pitches through the deadline.
Each line took major pressure. The second half turns on how the four collide inside health plans operating across all of them.
MedPAC put $45 billion in MA overpayments in front of Congress this week. Plans are about to evaluate vendors differently.
Why every health tech vendor that touches a member is now in the Stars math.
One plan's 2026 Star Rating got set aside. The reasoning asks if large parts of the program were ever legal. What that means for people who sell to, invest in, or advise plans.
